fda warning letters bpc-157 2023 Letter to Neil R. Feins, M.D. 2009-05-20 Multifunctionality and Possible Medical Application
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 131.Knezevic M., Gojkovic S., Krezic I., Zizek H., Malekinusic D., Vrdoljak B., Knezevic T., Vranes H., Drmic D., Staroveski M., et al
Therefore, it is not recommended to add ramucirumab to cisplatin plus fluoropyrimidine chemotherapy as first-line therapy
Vanichkachorn, J
A misread of even 2-3 units at a 5 mg/mL concentration changes your dose by 0.1-0.15 mg
For example, a protocol requiring 100 mcg doses is easier to measure with a higher concentration (less volume per dose)
